Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Zelluna ASA Director's Dealing 2021

Dec 2, 2021

3779_dirs_2021-12-02_d89526f6-5d23-478a-a732-293252e853f0.html

Director's Dealing

Open in viewer

Opens in your device viewer

Ultimovacs ASA: Mandatory notification of trade by primary insider

Ultimovacs ASA: Mandatory notification of trade by primary insider

Oslo, 2 December 2021, Carlos de Sousa, Chief Executive Officer and primary

insider in Ultimovacs ASA, has today bought 1,000 shares in the company at a

price of NOK 107.60 per share. Following this transaction, Carlos de Sousa and

closely related parties hold 15,056 shares and 416,035 share options in

Ultimovacs ASA.

This information is subject to the disclosure requirements pursuant to the

Market Abuse Regulation article 19 and section 5-12 of the Norwegian Securities

Trading Act.